dc.contributor.author | Karamustafalioglu, N. | |
dc.contributor.author | Emul, M. | |
dc.contributor.author | Genc, A. | |
dc.contributor.author | Kalelioglu, T. | |
dc.contributor.author | Durak, N. | |
dc.contributor.author | Balcioglu, Y. H. | |
dc.date.accessioned | 2021-03-06T20:57:27Z | |
dc.date.available | 2021-03-06T20:57:27Z | |
dc.identifier.citation | Balcioglu Y. H. , Kalelioglu T., Durak N., Karamustafalioglu N., Genc A., Emul M., "Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia", 29th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Vienna, Avusturya, 17 - 20 Eylül 2016, cilt.26 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_fc91545b-57f7-49be-8760-23a1e2aff01a | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/165286 | |
dc.identifier.uri | https://doi.org/10.1016/s0924-977x(16)31646-7 | |
dc.language.iso | eng | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Psikiyatri | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Nöroloji | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | NEUROSCIENCES | |
dc.subject | Temel Bilimler | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Sinirbilim ve Davranış | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia | |
dc.type | Bildiri | |
dc.contributor.department | Istanbul Bakirkoy Mental Health & Neurology Training & Research Hospital , , | |
dc.identifier.volume | 26 | |
dc.contributor.firstauthorID | 150242 | |